News

Yale, CORE, IV fluids, diuretics, heart failure, study

Many patients hospitalized with severe heart failure are receiving potentially harmful treatment with intravenous fluids, a Yale-led study has found.

blood pressure, systolic, hypertension, younger adults, cardiovascular, risk

Younger adults with elevated systolic blood pressure have a higher risk for cardiovascular disease and coronary heart disease than those with normal blood pressure, according to a large long-...

Ablation system, atrial fibrillation, Medtronic Arctic Front Advance Cryoballoon

Medtronic announced the initiation of the Cryo4 Persistent AF (Cryoballoon Ablation for Early Persistent Atrial Fibrillation) clinical trial.

Ostar Healthcare Technology announced the North American launch of their Cellular P201 telehealth blood pressure monitoring system. This advanced chronic disease remote monitoring system...

Millions of people take angiotensin receptor blockers (ARBs) to help treat heart failure. But it turns out not all ARBs are created equally, according to one Nova Southeastern University (NSU)...

Blood pressure monitoring, hypertension, heart failure, remote monitoring, OSTAR

Ostar Healthcare Technology, a Washington State Based TeleHealth Solutions company, announced the North American launch of Cellular TeleHealth Blood Pressure Monitoring System.

ASCERT, coronary bypass graft surgery, angioplasty, quality of life, value

Coronary bypass graft surgery commonly used to treat patients with coronary heart disease results in improved quality of life but also costs more than another often-used less invasive technique,...

Stem Cell Therapy, Congenital heart, clinical trial/study

Researchers at Okayama University and Okayama University Hospital show that children suffering from a condition known as hypoplastic left heart syndrome experienced some improvement in cardiac...

Artificial Heart, Ventricular Assist Device, Heart failure, SynCardia

SynCardia Systems Inc. has received U.S. Food and Drug Administration (FDA) approval to conduct a clinical study of the effectiveness of the SynCardia temporary Total Artificial Heart for...

Cardiac Resynchonization Therapy (CRT), Implantable cardioverster defibrillators

Medtronic announced new results from the PainFree SST and Shock-Less clinical studies published in the journal HeartRhythm.

Clinical trial/Study, Heart Valve Repair, CoreValve System

Medtronic revealed new one-year clinical data showing that transcatheter aortic valve replacement (TAVR) with the self-expanding CoreValve System offers advantages in survival and safety compared...

Thoratec, HeartMate III, VAD, NewYork Presbyterian, trial, ventricular assist

NewYork-Presbyterian Hospital/Columbia University Medical Center is one of a select group of medical centers participating in a clinical trial of a new device for advanced heart failure patients,...

clinical trial/study, imaging, CT imaging

According to a study published online in the Journal of the American College of Radiology (JACR), large majorities of primary care physicians believe that advanced medical...

clinical trial/study, stem cell therapies, Lifelines by Lori

The British Heart Foundation (BHF) announced the winners of its annual ‘Reflections of Research’ image competition – reflecting the charity’s research into heart and circulatory diseases.

CardioKinetix Inc. announced the completion of enrollment in Parachute China, a multi-center trial to evaluate the minimally invasive Parachute Ventricular Partitioning Device for the treatment of...

St. Jude, STAR-VT, ventricular tachycardia, ablation catheter, FlexAbility

St. Jude Medical Inc. announced the first patient enrollment in the STAR-VT (Substrate Targeted Ablation using the FlexAbility Ablation...

antiplatelet therapy, pharmaceuticals, cath lab, clinical trial, ticagrelor

AstraZeneca announced that the PEGASUS-TIMI 54 study, a large-scale outcomes trial involving more than 21,000...

Clinical trial/study, EP Lab, WRAP Infection Clinical Trial

Medtronic Inc. announced the first patient enrollment in the WRAP Infection Clinical Trial, which will evaluate the effectiveness of the TYRX Absorbable Antibacterial Envelope in reducing major...

In a rural Maine county, sustained community-wide programs targeting cardiovascular risk factors and behavior changes were associated with reductions in hospitalization and death rates over a 40-...

rivaroxaban, Xarelto, safety performance, Janssen, NVAF

A new post-marketing study evaluating the safety of once-daily rivaroxaban (Xarelto) shows, in patients with non-valvular atrial fibrillation (NVAF), rates and patterns of major...